News

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...
But behind the headlines and hashtags lies a disturbing trend that deserves urgent attention: the rise of compounded GLP-1s ...
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight ...
A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...
The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and ...
Apple cider vinegar can cause side effects when taking it and certain medications. Learn which medications apple cider ...
A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists ...
To truly shift the landscape in obesity care, explains Jaime Almandoz, MD, MBA, UT Southwestern, care models and policies ...
How involved will GPs be in tirzepatide prescribing, and how do we approach conversations about 'prioritising' domestic ...
Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...
Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...